ARID1A functions as a tumor suppressor gene in lung tissue and is mutated in approximately 8%–10% of patients with NSCLC, mainly as LoF alterations frequently associated with the loss of protein expression [13, 16, 37, 38]. Here, ARID1A is linked to non-small cell lung carcinoma.